Caitong International Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$334K Buy
3,364
+3,363
+336,300% +$439K 0.06% 259
2025
Q4
$122 Sell
1
-158
-99% -$19.8K ﹤0.01% 1679
2025
Q3
$17.8K Buy
+159
New +$18.6K 0.01% 760
2025
Q2
Sell
-41
Closed -$2.76K 2483
2025
Q1
$2.76K Sell
41
-1,855
-98% -$128K ﹤0.01% 1221
2024
Q4
$118K Buy
+1,896
New +$176K 0.12% 197

Other funds holding TMDX

Caitong International Asset Management's TMDX Position: Q1 2026 in Review

Caitong International Asset Management increased its Transmedics (TMDX) stake by 336,300% in Q1 2026, buying an estimated $439K and bringing the position to 3,364 shares worth $334K. The position accounts for 0.06% of the portfolio, ranked #259.

Caitong International Asset Management first reported a position in TMDX in Q4 2024 and has held it in 5 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Caitong International Asset Management held 3,364 shares of Transmedics worth $334K as of Q1 2026.
  • Caitong International Asset Management bought 3,363 Transmedics shares in Q1 2026, an estimated $439K.
  • Transmedics made up 0.06% of Caitong International Asset Management's portfolio in Q1 2026, its #259 holding.
  • Caitong International Asset Management first reported a position in Transmedics in Q4 2024 and has held it in 5 quarters since.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.